{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T14:55:15Z","timestamp":1791903315510,"version":"4.3.4"},"reference-count":46,"publisher":"American Society of Hematology","issue":"19","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,10,13]]},"abstract":"<jats:sec>\n                    <jats:title>Abstract<\/jats:title>\n                    <jats:p>The plasminogen activation and plasmin activity (PA) system is a central mechanism for degrading fibrin and has long been viewed as essential for preventing venous thrombosis\/thromboembolism. However, clinical and experimental data challenge this paradigm. Here, we examine evidence that reduced PA does not predispose individuals to venous thrombosis\/thromboembolism. We discuss potential mechanisms that may rationalize this apparent paradox, including compensatory vascular and inflammatory pathways that may degrade intravascular fibrin. These data suggest venous thromboembolism is a multifactorial disease in which an impaired PA system is neither necessary nor sufficient to drive thrombosis. We also discuss alternative biological roles of the PA system. Reframing the role of the PA system has important implications for developing therapies that modulate fibrinolysis. A more nuanced understanding of PA biology may enable strategies that balance bleeding risk with efficient clot resolution.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1182\/bloodadvances.2025018558","type":"journal-article","created":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T23:28:38Z","timestamp":1784590118000},"page":"6661-6665","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":0,"title":["Venous thromboembolism is not associated with plasmin(ogen): reevaluating plasmin and mechanisms that degrade fibrin"],"prefix":"10.1182","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5147-989X","authenticated-orcid":false,"given":"Yaqiu","family":"Sang","sequence":"first","affiliation":[{"name":"1Department of Pathology and Laboratory Medicine and UNC Blood Research Center, The University of North Carolina at Chapel Hill, Chapel Hill, NC"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2821-7159","authenticated-orcid":false,"given":"Amy D.","family":"Shapiro","sequence":"additional","affiliation":[{"name":"2Indiana Hemophilia and Thrombosis Center, Indianapolis, IN"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2845-2303","authenticated-orcid":false,"given":"Alisa S.","family":"Wolberg","sequence":"additional","affiliation":[{"name":"1Department of Pathology and Laboratory Medicine and UNC Blood Research Center, The University of North Carolina at Chapel Hill, Chapel Hill, NC"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","published-online":{"date-parts":[[2026,9,29]]},"reference":[{"issue":"1","key":"2026101310425316200_bib1","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.blre.2014.09.003","article-title":"Fibrinolysis and the control of blood coagulation","volume":"29","author":"Chapin","year":"2015","journal-title":"Blood Rev"},{"issue":"21","key":"2026101310425316200_bib2","doi-asserted-by":"crossref","first-page":"2881","DOI":"10.1182\/blood.2020008951","article-title":"Plasminogen: an enigmatic zymogen","volume":"137","author":"Keragala","year":"2021","journal-title":"Blood"},{"issue":"6","key":"2026101310425316200_bib3","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1111\/j.1365-2516.2008.01825.x","article-title":"Plasminogen deficiency","volume":"14","author":"Mehta","year":"2008","journal-title":"Haemophilia"},{"issue":"7","key":"2026101310425316200_bib4","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1101\/gad.9.7.794","article-title":"Plasminogen deficiency causes severe thrombosis but is compatible with development and reproduction","volume":"9","author":"Bugge","year":"1995","journal-title":"Genes Dev"},{"issue":"4","key":"2026101310425316200_bib5","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/S0092-8674(00)81390-2","article-title":"Loss of fibrinogen rescues mice from the pleiotropic effects of plasminogen deficiency","volume":"87","author":"Bugge","year":"1996","journal-title":"Cell"},{"issue":"1","key":"2026101310425316200_bib6","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1111\/bjh.14255","article-title":"Bleeding related to disturbed fibrinolysis","volume":"175","author":"Kolev","year":"2016","journal-title":"Br J Haematol"},{"issue":"3","key":"2026101310425316200_bib7","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1111\/j.1464-410X.1966.tb09717.x","article-title":"The effect of epsilon aminocaproic acid on the blood loss after retropubic prostatectomy","volume":"38","author":"Lawrence","year":"1966","journal-title":"Br J Urol"},{"issue":"7431","key":"2026101310425316200_bib8","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/S0140-6736(66)90051-1","article-title":"Aminocaproic acid in the control of haemorrhage after prostatectomy. A controlled trial","volume":"1","author":"Vinnicombe","year":"1966","journal-title":"Lancet"},{"key":"2026101310425316200_bib9","doi-asserted-by":"crossref","first-page":"e12546","DOI":"10.1002\/rth2.12546","article-title":"Tranexamic acid evidence and controversies: an illustrated review","volume":"5","author":"Relke","year":"2021","journal-title":"Res Pract Thromb Haemost"},{"issue":"10084","key":"2026101310425316200_bib10","doi-asserted-by":"crossref","first-page":"2105","DOI":"10.1016\/S0140-6736(17)30638-4","article-title":"Effect of early tranexamic acid administration on mortality, hysterectomy, and other morbidities in women with post-partum haemorrhage (WOMAN): an international, randomised, double-blind, placebo-controlled trial","volume":"389","author":"WOMAN Trial Collaborators","year":"2017","journal-title":"Lancet"},{"issue":"9734","key":"2026101310425316200_bib11","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S0140-6736(10)60835-5","article-title":"Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial","volume":"376","author":"Shakur","year":"2010","journal-title":"Lancet"},{"issue":"10210","key":"2026101310425316200_bib12","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1016\/S0140-6736(19)32233-0","article-title":"Effects of tranexamic acid on death, disability, vascular occlusive events and other morbidities in patients with acute traumatic brain injury (CRASH-3): a randomised, placebo-controlled trial","volume":"394","author":"CRASH-3 trial collaborators","year":"2019","journal-title":"Lancet"},{"issue":"2","key":"2026101310425316200_bib13","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1056\/NEJMoa1606424","article-title":"Tranexamica acid in patients undergoing coronary-artery surgery","volume":"376","author":"Myles","year":"2017","journal-title":"N Engl J Med"},{"issue":"21","key":"2026101310425316200_bib14","doi-asserted-by":"crossref","first-page":"1986","DOI":"10.1056\/NEJMoa2201171","article-title":"Tranexamic acid in patients undergoing noncardiac surgery","volume":"386","author":"Devereaux","year":"2022","journal-title":"N Engl J Med"},{"issue":"1","key":"2026101310425316200_bib15","first-page":"11","article-title":"Tranexamic acid during prehospital transport in patients at risk for hemorrhage after injury: a double-blind, placebo-controlled, randomized clinical trial","volume":"156","author":"Guyette","year":"2020","journal-title":"JAMA Surg"},{"issue":"3","key":"2026101310425316200_bib16","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1182\/blood-2004-08-3253","article-title":"Reduced plasma fibrinolytic potential is a risk factor for venous thrombosis","volume":"105","author":"Lisman","year":"2005","journal-title":"Blood"},{"issue":"1","key":"2026101310425316200_bib17","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1182\/blood-2010-02-267740","article-title":"Venous thrombosis risk associated with plasma hypofibrinolysis is explained by elevated plasma levels of TAFI and PAI-1","volume":"116","author":"Meltzer","year":"2010","journal-title":"Blood"},{"issue":"11","key":"2026101310425316200_bib18","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1161\/CIRCULATIONAHA.116.024421","article-title":"Releasing the brakes on the fibrinolytic system in pulmonary emboli: unique effects of plasminogen activation and \u03b12-antiplasmin inactivation","volume":"135","author":"Singh","year":"2017","journal-title":"Circulation"},{"issue":"12","key":"2026101310425316200_bib19","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1182\/blood.2019000049","article-title":"Venous stasis-induced fibrinolysis prevents thrombosis in mice: role of \u03b12-antiplasmin","volume":"134","author":"Singh","year":"2019","journal-title":"Blood"},{"issue":"8","key":"2026101310425316200_bib20","doi-asserted-by":"crossref","first-page":"1734","DOI":"10.1046\/j.1538-7836.2003.00252.x","article-title":"Alpha2-antiplasmin plays a significant role in acute pulmonary embolism","volume":"1","author":"Matsuno","year":"2003","journal-title":"J Thromb Haemost"},{"issue":"7","key":"2026101310425316200_bib21","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1002\/bjs.1800590706","article-title":"The effect of the fibrinolytic inhibitor epsilon-aminocaproic acid on the incidence of deep-vein thrombosis after prostatectomy","volume":"59","author":"Gordon-Smith","year":"1972","journal-title":"Br J Surg"},{"key":"2026101310425316200_bib46","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/S0140-6736(66)90052-3","article-title":"Aminocaproic acid in the control of haemorrhage afterprostatectomy. Safety of aminocaproic acid\u2013a controlled trial","volume":"1","author":"Vinnicombe","year":"1966","journal-title":"Lancet"},{"issue":"10135","key":"2026101310425316200_bib22","doi-asserted-by":"crossref","first-page":"2107","DOI":"10.1016\/S0140-6736(18)31033-X","article-title":"Tranexamic acid for hyperacute primary IntraCerebral Haemorrhage (TICH-2): an international randomised, placebo-controlled, phase 3 superiority trial","volume":"391","author":"Sprigg","year":"2018","journal-title":"Lancet"},{"issue":"24","key":"2026101310425316200_bib23","doi-asserted-by":"crossref","first-page":"2419","DOI":"10.1056\/NEJMoa2515820","article-title":"Hospital policy of tranexamic acid to reduce transfusion in major noncardiac surgery","volume":"394","author":"Houston","year":"2026","journal-title":"N Engl J Med"},{"issue":"1","key":"2026101310425316200_bib24","doi-asserted-by":"crossref","first-page":"85.e1","DOI":"10.1016\/j.ajog.2020.11.035","article-title":"Optimal use of intravenous tranexamic acid for hemorrhage prevention in pregnant women","volume":"225","author":"Ahmadzia","year":"2021","journal-title":"Am J Obstet Gynecol"},{"issue":"6","key":"2026101310425316200_bib25","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1182\/bloodadvances.2022008255","article-title":"Absence of hyperfibrinolysis may explain lack of efficacy of tranexamic acid in hypoproliferative thrombocytopenia","volume":"7","author":"Ilich","year":"2023","journal-title":"Blood Adv"},{"issue":"23","key":"2026101310425316200_bib26","doi-asserted-by":"crossref","first-page":"6031","DOI":"10.1182\/bloodadvances.2025017046","article-title":"Impact of tranexamic acid on postpartum hemorrhage in type 1 von Willebrand disease treated with recombinant VWF","volume":"9","author":"Machin","year":"2025","journal-title":"Blood Adv"},{"issue":"2","key":"2026101310425316200_bib27","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1001\/jamasurg.2017.3821","article-title":"Evaluation of military use of tranexamic acid and associated thromboembolic events","volume":"153","author":"Johnston","year":"2018","journal-title":"JAMA Surg"},{"issue":"1","key":"2026101310425316200_bib28","doi-asserted-by":"crossref","first-page":"e000353","DOI":"10.1136\/tsaco-2019-000353","article-title":"TXA (tranexamic acid) risk evaluation in combat casualties (TRECC)","volume":"5","author":"Adair","year":"2020","journal-title":"Trauma Surg Acute Care Open"},{"issue":"1","key":"2026101310425316200_bib29","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1097\/TA.0000000000002061","article-title":"Tranexamic acid administration is associated with an increased risk of posttraumatic venous thromboembolism","volume":"86","author":"Myers","year":"2019","journal-title":"J Trauma Acute Care Surg"},{"key":"2026101310425316200_bib30","doi-asserted-by":"crossref","first-page":"100882","DOI":"10.1016\/j.eclinm.2021.100882","article-title":"Oral tranexamic acid and thrombosis risk in women","volume":"35","author":"Meaidi","year":"2021","journal-title":"EClinicalMedicine"},{"key":"2026101310425316200_bib31","doi-asserted-by":"crossref","first-page":"1927","DOI":"10.1016\/S0140-6736(20)30848-5","article-title":"Effects of a high-dose 24-h infusion of tranexamic acid on death and thromboembolic events in patients with acute gastrointestinal bleeding (HALT-IT): an international randomised, double-blind, placebo-controlled trial","volume":"395","author":"HALT-IT Trial Collaborators","year":"2020","journal-title":"Lancet"},{"issue":"11","key":"2026101310425316200_bib32","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1182\/blood.2025028680","article-title":"Plasminogen activation and plasmin activity are not necessary to prevent venous thrombosis\/thromboembolism","volume":"146","author":"Sang","year":"2025","journal-title":"Blood"},{"issue":"9401","key":"2026101310425316200_bib33","doi-asserted-by":"crossref","first-page":"2039","DOI":"10.1016\/S0140-6736(03)15097-0","article-title":"Frequency of venous thromboembolism in low to moderate risk long distance air travellers: the New Zealand Air Traveller's Thrombosis (NZATT) study","volume":"362","author":"Hughes","year":"2003","journal-title":"Lancet"},{"issue":"4","key":"2026101310425316200_bib34","first-page":"342","article-title":"Degradation of cross-linked fibrin by human leukocyte proteases","volume":"107","author":"Francis","year":"1986","journal-title":"J Lab Clin Med"},{"issue":"5","key":"2026101310425316200_bib35","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1055\/s-0037-1613306","article-title":"Influence of plasminogen deficiency on the contribution of polymorphonuclear leucocytes to fibrin\/ogenolysis: studies in plasminogen knock-out mice","volume":"88","author":"Zeng","year":"2002","journal-title":"Thromb Haemost"},{"issue":"2","key":"2026101310425316200_bib36","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1172\/JCI110462","article-title":"Elastase of U-937 monocytelike cells. Comparisons with elastases derived from human monocytes and neutrophils and murine macrophagelike cells","volume":"69","author":"Senior","year":"1982","journal-title":"J Clin Invest"},{"issue":"8","key":"2026101310425316200_bib37","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1097\/00001721-199512000-00001","article-title":"Role of neutrophil membrane proteases in fibrin degradation","volume":"6","author":"Adams","year":"1995","journal-title":"Blood Coagul Fibrinolysis"},{"issue":"1","key":"2026101310425316200_bib38","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1111\/j.1699-0463.1999.tb01527.x","article-title":"Human homozygous type I plasminogen deficiency and ligneous conjunctivitis","volume":"107","author":"Mingers","year":"1999","journal-title":"APMIS"},{"issue":"2","key":"2026101310425316200_bib39","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1160\/TH17-05-0348","article-title":"Neutrophil elastase-derived fibrin degradation products indicate presence of abdominal aortic aneurysms and correlate with intraluminal thrombus volume","volume":"118","author":"Lindquist Liljeqvist","year":"2018","journal-title":"Thromb Haemost"},{"issue":"7","key":"2026101310425316200_bib40","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1084\/jem.193.7.793","article-title":"Matrix metalloproteinase 9 protects mice from anti-glomerular basement membrane nephritis through its fibrinolytic activity","volume":"193","author":"Lelongt","year":"2001","journal-title":"J Exp Med"},{"issue":"4","key":"2026101310425316200_bib41","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1111\/jth.14768","article-title":"Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia","volume":"18","author":"Tang","year":"2020","journal-title":"J Thromb Haemost"},{"issue":"1","key":"2026101310425316200_bib42","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1161\/ATVBAHA.120.315338","article-title":"COVID-19 and sepsis are associated with different abnormalities in plasma procoagulant and fibrinolytic activity","volume":"41","author":"Bouck","year":"2021","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"4","key":"2026101310425316200_bib43","doi-asserted-by":"crossref","first-page":"e20191865","DOI":"10.1084\/jem.20191865","article-title":"A critical role for plasminogen in inflammation","volume":"217","author":"Baker","year":"2020","journal-title":"J Exp Med"},{"key":"2026101310425316200_bib44","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.ebiom.2016.02.011","article-title":"Complement activation in arterial and venous thrombosis is mediated by plasmin","volume":"5","author":"Foley","year":"2016","journal-title":"EBioMedicine"},{"issue":"15","key":"2026101310425316200_bib45","doi-asserted-by":"crossref","first-page":"1850","DOI":"10.1182\/blood.2025028959","article-title":"Plasminogen as a ribonucleoprotein: regulatory small RNA cargo modulates fibrinolysis and inflammation","volume":"146","author":"Michell","year":"2025","journal-title":"Blood"}],"container-title":["Blood Advances"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/10\/19\/6661\/2592406\/blooda_adv-2025-018558-c-main.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/10\/19\/6661\/2592406\/blooda_adv-2025-018558-c-main.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T14:43:03Z","timestamp":1791902583000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article\/10\/19\/6661\/569771\/Venous-thromboembolism-is-not-associated-with"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,29]]},"references-count":46,"journal-issue":{"issue":"19","published-print":{"date-parts":[[2026,10,13]]}},"URL":"https:\/\/doi.org\/10.1182\/bloodadvances.2025018558","relation":{},"ISSN":["2473-9529","2473-9537"],"issn-type":[{"value":"2473-9529","type":"print"},{"value":"2473-9537","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,10,13]]},"published":{"date-parts":[[2026,9,29]]}}}